Brain stem cell transplant aims to restore movement after stroke
Disease control
Not yet recruiting
This phase 2b trial tests whether injecting allogeneic neural stem cells (CC-101) into the brain near a prior stroke lesion can improve motor function in adults with chronic ischemic stroke and lasting movement problems. About 36 participants will receive either stem cells plus s…
Phase: PHASE2 • Sponsor: Clarion Cells, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC